CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Budesonide

Last Updated: April 26, 2016
Result type: Reports
Project Number: SR0491-000
Product Line: Reimbursement Review

Generic Name: Budesonide

Brand Name: Cortiment

Manufacturer: Ferring Inc.

Therapeutic Area: Ulcerative Colitis

Indications: Ulcerative Colitis

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: March 22, 2017

Recommendation Type: Do not reimburse